Monoclonal Antibodies Transforming the Alzheimer’s Drugs Market Through 2031
The growing prevalence of Alzheimer's disease, rapidly aging population, and increasing investments in neurological drug development are driving the expansion of the global Alzheimer's Drugs Market. Alzheimer's disease is a progressive neurological disorder that affects memory, cognitive abilities, and daily functioning. The increasing need for effective treatments, combined with advancements...